Sarepta Therapeutics, Inc. SRPT
Set alert
18.32 USD -0.30 -1.61%
At close
18.30 -0.02 -0.11%
Pre-market · Nov 3, 4:00 AM ET
18.10 Day range 18.90
14.68 52-week range 24.68
- YTD
- -14.87%
- 1 year
- -23.70%
- Open
- 18.65
- Prev close
- 18.62
- Mkt cap
- 1.94B
- Vol
- 1.16M
- Avg vol
- 2.90M
- EPS
- -1.57
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 18.10
- High
- 18.90
- Forward P/E
- 7.48
- Beta
- 0.45
- Short ratio
- 7.84
- Inst. own
- 103.44%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 19.24
- 200-d avg
- 18.72
- 1y target
- 21.64
5D chart
Signals (110)
| Name | Time | Ago |
|---|---|---|
| MACD: Sell Signal | Nov 2, 3:35 PM | 14 hours ago |
| SMA: Bearish | Nov 2, 3:25 PM | 14 hours ago |
| SMA: Bearish | Nov 2, 3:10 PM | 14 hours ago |
| MACD: Buy Signal | Nov 2, 2:15 PM | 15 hours ago |
| SMA: Bullish | Nov 2, 2:10 PM | 15 hours ago |
| RSI: Oversold | Nov 2, 1:55 PM | 16 hours ago |
| RSI: Oversold | Nov 2, 1:40 PM | 16 hours ago |
| MACD: Sell Signal | Nov 2, 1:30 PM | 16 hours ago |
| SMA: Bullish | Nov 2, 12:55 PM | 17 hours ago |
| MACD: Buy Signal | Nov 2, 12:55 PM | 17 hours ago |
| MACD: Sell Signal | Nov 2, 12:45 PM | 17 hours ago |
| MACD: Buy Signal | Nov 2, 11:40 AM | 18 hours ago |
| SMA: Bullish | Nov 2, 11:30 AM | 18 hours ago |
| SMA: Bullish | Nov 2, 10:20 AM | 19 hours ago |
| SMA: Bearish | Nov 2, 10:15 AM | 19 hours ago |
| MACD: Sell Signal | Nov 2, 10:10 AM | 19 hours ago |
| SMA: Bearish | Nov 2, 10:00 AM | 20 hours ago |
| RSI: Overbought | Nov 2, 9:30 AM | 20 hours ago |
| SMA: Bullish | Oct 30, 3:05 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:30 PM | 3 days ago |
Newest 20 of 110.
Financial health
Altman Z-Score
-0.09 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 4
Valuation
P/E -3.0×
FY 2016 5y median -16.1× FY 2025
P/S 1.0×
FY 2016 5y median 7.2× FY 2025
P/B 2.0×
FY 2016 5y median 7.9× FY 2025
P/FCF -7.3×
FY 2016 5y median -15.2× FY 2025
EV/EBITDA -3.8×
FY 2016 5y median -20.0× FY 2025
EV/Sales 1.1×
FY 2016 5y median 7.9× FY 2025
FCF Yield -13.6%
FY 2016 5y median -6.6% FY 2025
Profitability
Gross Margin 59.9%
FY 2016 5y median 85.0% FY 2025
Operating Margin -29.9%
FY 2016 5y median -29.9% FY 2025
Net Margin -32.5%
FY 2016 5y median -43.1% FY 2025
ROE -62.5%
FY 2016 5y median -62.4% FY 2025
ROIC -29.0%
FY 2016 5y median -17.0% FY 2025
ROA -21.3%
FY 2016 5y median -16.4% FY 2025
Growth (YoY)
Revenue 15.6%
FY 2016 FY 2025
Operating Income -401.6%
FY 2016 FY 2025
EPS (diluted) -404.7%
FY 2016 FY 2025
Free Cash Flow 12.8%
FY 2016 FY 2025
Financial Health
Current Ratio 2.3×
FY 2016 5y median 4.1× FY 2025
Quick Ratio 1.5×
FY 2016 5y median 3.5× FY 2025
Debt / Equity 0.9×
FY 2016 5y median 1.2× FY 2025
Net Debt / EBITDA -0.4×
FY 2016 5y median -0.4× FY 2025
Interest Coverage -67.6×
FY 2016 5y median -10.1× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
